You have questions, we have answers. Here’s a representative sample of recent reader letters on a range of timely topics, with our responses. Read More
Analyst Articles
The mainstreaming of psychedelics poses a huge investment opportunity, especially after a watershed legal development this week in Oregon. Read More
We're in the midst of a rally during a recession, but the bubble is likely to soon burst. Here's how to allocate your assets, for defensive growth. Read More
Many investors expect a vaccine to miraculously emerge and kill the coronavirus, thereby rescuing the economy and markets. Don’t bet on it. Read More
During the coronavirus-caused recession, the feds are aggressively removing post-2008 banking safeguards. That should worry you. Read More
Misinformation is exacerbating market volatility, yet another sign that investors should tread carefully. Here's how to trade. Read More
A new government report recommends psilocybin fungi for psychiatric treatment. The legalization of 'shrooms is gaining steam. Read More
Since their pandemic lows, stocks have been on a reckless run. Here’s how to protect your portfolio, before the market derails. Read More
The stock market rally is out of whack with the fundamentals. Here’s a look at investor exuberance and why it probably won't last. Read More
Here’s a round-up of the latest legal and regulatory trends affecting the marijuana industry and what they portend for investors. Read More